Evidence map›Paper›PMID 1378622›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1992

Association of the erythropoietin receptor with protein tyrosine kinase activity.

D Linnekin, G A Evans, A D'Andrea, W L Farrar

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1992. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Activated Ki-Ras complements erythropoietin signaling in CTLL-2 cells, inducing tyrosine phosphorylation of a 160-kDa protein.Proceedings of the National Academy of Sciences of the United States of America · 1994
    Article
  4. Review
  5. Ligand-induced activation of chimeric receptors between the erythropoietin receptor and receptor tyrosine kinases.Proceedings of the National Academy of Sciences of the United States of America · 1994
    Article
  6. Article
  7. Article
  8. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis.Proceedings of the National Academy of Sciences of the United States of America · 1993
    Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

D LinnekinLaboratory of Molecular Immunoregulation, National Cancer Institute, Frederick Cancer Research and Development Center, MD 21702-1201.
G A Evans
A D'Andrea
W L Farrar
National Cancer Institute · US

Funding

OPERATIONS AND TECHNICAL SUPPORTN01CO074102 · CO · PROGRAM RESOURCES, INC. · PI COMPTON, THOMAS F · 1987 to 1998
–
NCI NIH HHS N01-CO-74102
6 · The paper itself

Abstract

We have examined the signal transduction mechanism of the hematopoietic growth factor erythropoietin (Epo). Epo stimulation of Ba/F3 cells transfected with the Epo receptor resulted in increases in tyrosine phosphorylation of proteins of 97, 75, and 55 kDa. Epo-induced increases in tyrosine phosphorylation of a 97-kDa protein were also detected within the Epo receptor complex, suggesting that a protein tyrosine kinase is associated with the Epo receptor. Protein tyrosine kinase activity was found within the Epo receptor complex and modulation of this activity was observed after treatment of cells with Epo. Furthermore, constitutively high amounts of protein kinase activity were observed in Epo receptor complexes isolated from autonomously growing cells coexpressing the Epo receptor and the leukemogenic glycoprotein gp55. The dominant phosphotyrosylprotein found associated with the Epo receptor was 97 kDa. An Epo receptor-associated protein of identical molecular mass was also found to bind ATP, a characteristic critical for protein kinases. Collectively, these data demonstrate that the Epo receptor is associated with protein tyrosine kinase activity and further suggest that a 97-kDa phosphotyrosylprotein associated with the Epo receptor is a protein tyrosine kinase involved in Epo-mediated signal transduction.

Indexed as

Adenosine TriphosphateAnimalsElectrophoresis, Gel, Two-DimensionalErythropoietinFriend murine leukemia virusGene Products, envMacromolecular SubstancesMiceMolecular WeightPhosphoproteinsPhosphorylationPhosphotyrosineProtein-Tyrosine KinasesReceptors, Cell SurfaceReceptors, ErythropoietinSignal TransductionAdenosine TriphosphateErythropoietinGene Products, envMacromolecular SubstancesPhosphoproteinsPhosphotyrosineProtein-Tyrosine KinasesReceptors, Cell SurfaceReceptors, ErythropoietinTyrosine

Identifiers

PMID1378622
PMCPMC49475
OpenAlexW2083482330

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.